angiotensin ii has been researched along with lignans in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM | 1 |
| Cosentino, M; Delle Canne, MG; Lecchini, S; Luzzani, M; Maio, RC; Marino, F; Paracchini, S | 1 |
| Chen, Y; Han, X; Li, D; Li, Y; Liu, X; Weng, X; Yang, Q; Zhu, X; Zou, L | 1 |
| Jin Lee, S; Kim, CD; Ung Bae, J; Whan Choi, Y; Whan Hong, K; Won Seo, K; Wook Yun, J; Youn Park, S; Young Park, J | 1 |
| Alexander, JS; Wang, Y | 1 |
| Choi, YW; Kim, CD; Lee, SJ; Park, SY; Ye, BH | 1 |
| Kong, X; Li, W; Ren, Y; Wu, Y; Xuan, J; Yang, J; Zhao, M; Zheng, S | 1 |
| Kong, X; Ren, YN; Tao, SJ; Yang, JR; Zhao, MQ; Zheng, SG | 1 |
| Bu, P; Huang, C; Li, J; Li, N; Liu, H; Shan, X; Yan, X; Yang, Y; Zhang, C; Zhang, J; Zhang, P; Zhang, Y | 1 |
| Han, J; Jiang, L; Shi, F; Shi, X; Xu, J; Zhang, B; Zheng, Z | 1 |
| Du, Y; Han, J; Jiang, L; Shi, F; Shi, X; Xu, J; Zhang, B; Zheng, Z | 1 |
| Chung, MH; Hong, EY; Hong, GU; Kang, H; Kim, SC; Kim, TY; Kim, YH; Kwon, YI; Lee, JY; Park, JY; Ro, JY | 1 |
| Chen, T; Huang, W; Liang, G; Qian, J; Qian, Y; Wang, J; Wang, Z; Wu, G; You, S | 1 |
| Chi, Z; Guo, E; Kim, D; Kim, JH; Le, TPH; Lee, S; Lee, SK; Lee, SY; Seo, SY | 1 |
14 other study(ies) available for angiotensin ii and lignans
| Article | Year |
|---|---|
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction | 1988 |
Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/lignan) extracted from the heartwood of Norway spruce (Picea abies).
Topics: Angiotensin II; Cell Line, Tumor; Humans; Immunologic Factors; In Vitro Techniques; Interleukin-8; Lignans; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Picea; Plant Extracts; Reactive Oxygen Species; Respiratory Burst; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tumor Necrosis Factor-alpha; Wood | 2010 |
[Influence of Tiangou Jiangya capsule on blood pressure in renovascular hypertension rats].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzyl Alcohols; Blood Pressure; Drugs, Chinese Herbal; Flavonoids; Furans; Glucosides; Hypertension, Renovascular; Lignans; Rats; Rats, Wistar; Renin; Renin-Angiotensin System | 2011 |
Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Cells, Cultured; Cyclooctanes; Dioxoles; Dose-Response Relationship, Drug; Hypertension; Lignans; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Reactive Oxygen Species; Schisandra; Vasoconstrictor Agents | 2012 |
Therapeutic potential of Schisandra chinensis extracts for treatment of hypertension. Introduction to: 'antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability'
Topics: Angiotensin II; Animals; Antihypertensive Agents; Cyclooctanes; Dioxoles; Hypertension; Lignans; Male; Nitric Oxide; Schisandra; Vasoconstrictor Agents | 2012 |
Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Cyclooctanes; Dioxoles; Disease Models, Animal; Hypertension; Lignans; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Plant Extracts; Polycyclic Compounds; Reactive Oxygen Species; Schisandra; Treatment Outcome; Vasodilator Agents | 2015 |
Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antioxidants; Blood Pressure; Collagen Type I; Collagen Type III; Dioxoles; Fibroblasts; Fibrosis; Heart Ventricles; Lignans; Male; Malondialdehyde; Myocardium; NADPH Oxidases; Organ Size; Phosphorylation; Rats, Inbred SHR; Signal Transduction; Smad3 Protein; Smad7 Protein; Superoxide Dismutase; Systole; Transforming Growth Factor beta1 | 2015 |
[Effect of Serum Containing Sesamin on Angiotensin II-Induced Apoptosis in Rat Cardiomyocytes].
Topics: Angiotensin II; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line; Cell Survival; Dioxoles; Lignans; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Superoxide Dismutase | 2015 |
SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension.
Topics: Acetylation; Angiotensin II; Animals; Biphenyl Compounds; Disease Models, Animal; Fibrosis; Gene Expression; Gene Expression Regulation; Hypertension, Renal; Kidney; Kruppel-Like Transcription Factors; Lignans; Mice; Mice, Knockout; Models, Biological; Nephritis; Nuclear Proteins; Podocytes; Protein Binding; Signal Transduction; Sirtuin 3 | 2017 |
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway.
Topics: Angiotensin II; Animals; Cells, Cultured; Cyclooctanes; Endothelial Cells; Kelch-Like ECH-Associated Protein 1; Lignans; Male; NF-E2-Related Factor 2; Oxidative Stress; Polycyclic Compounds; Rats; Rats, Sprague-Dawley | 2018 |
Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium.
Topics: Angiotensin II; Animals; Antioxidants; Cells, Cultured; Cyclooctanes; Endothelium, Vascular; Kelch-Like ECH-Associated Protein 1; Lignans; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Polycyclic Compounds; Rats; Rats, Sprague-Dawley | 2019 |
Inhibitory Effects of Roseoside and Icariside E4 Isolated from a Natural Product Mixture (No-ap) on the Expression of Angiotensin II Receptor 1 and Oxidative Stress in Angiotensin II-Stimulated H9C2 Cells.
Topics: Angiotensin II; Animals; Biological Products; Chemokine CCL2; Gene Expression Regulation; Glucosides; Glycosides; Humans; Hydrogen Peroxide; Lignans; Norisoprenoids; Oxidation-Reduction; Oxidative Stress; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2019 |
Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-κB activation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Cells, Cultured; Cyclooctanes; Cytokines; Disease Models, Animal; Endothelium, Vascular; Fibrosis; Gene Expression Regulation; Inflammation; Lignans; Male; Mice; Mice, Inbred C57BL; NF-kappa B p50 Subunit; Oxidative Stress; Phenotype; Polycyclic Compounds; Signal Transduction; Vascular Remodeling | 2019 |
Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation.
Topics: Acetylation; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Cystathionine gamma-Lyase; Endothelial Cells; HEK293 Cells; Histone Deacetylase 6; Humans; Hydrogen Sulfide; Hypertension; Lignans; Male; Mice; Mice, Inbred C57BL; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Proteolysis; Recombinant Proteins | 2020 |